Parsons Corporation has been awarded a biological defense research contract to advance the Naval Medical Research Command’s (NMRC) mission to defend against the threat of biological and chemical warfare.
The $24 million contract consists of a one-year base period and four one-year option periods.
Under this contract, Parsons will continue to support NMRC’s Biological Defense Research Directorate (BDRD) in its efforts to facilitate biological research for the rapid detection of infectious diseases of Department of Defense importance and the enhancement of global disease surveillance for early pathogen detection and response.
“At Parsons, our team of world-class scientists combined with our industry-leading biodefense capabilities play a pivotal role in advancing the federal government’s efforts to counter biological threats,” said Jon Moretta, President, Engineered Systems, for Parsons.
“We look forward to continuing this critical work with the Naval Medical Research Command in defending US military personnel stationed around the world from threats to their health and safety.”
“Parsons has performed this work since 2018, providing NMRC with scientists who are subject matter experts in molecular biology, immunology, serology, bacteriology, laboratory science and management, field collection, field lab detection, outbreak response, production of reagents, and assay development,” said Parsons.
“The company offers a full spectrum of biodefense services, including risk assessments; biological threat detection, identification, and surveillance; incident response and management; and technical expertise on issues impacting biosecurity.”